SCHEDULE 13G/A: Dodge & Cox Discloses 10.2% Stake in Zimmer Biomet Holdings

Sentiment:

Beneficial Ownership Disclosure


Investment adviser Dodge & Cox has filed an amended Schedule 13G, disclosing a 10.2% beneficial ownership stake in Zimmer Biomet Holdings, Inc. as of April 30, 2025.

Summary

  • Dodge & Cox, an investment adviser based in California, USA, filed an Amendment No. 3 to Schedule 13G regarding its holdings in Zimmer Biomet Holdings, Inc.
  • As of April 30, 2025, Dodge & Cox beneficially owns 20,087,118 shares of Zimmer Biomet Holdings, Inc. Common Stock.
  • This ownership represents 10.2% of the total class of securities.
  • Dodge & Cox holds sole voting power over 18,974,543 shares and sole dispositive power over all 20,087,118 shares.
  • The filing indicates that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing the control of the issuer.
  • The Dodge & Cox Stock Fund, an investment company registered under the Investment Company Act of 1940, holds a significant portion of this stake, specifically 13,244,800 shares, which accounts for 6.7% of the class of securities.

Sentiment

Score: 5

Explanation: The document is a factual disclosure of ownership, carrying a neutral sentiment. It does not contain positive or negative performance metrics, forward-looking statements from the issuer, or any other information that would significantly sway sentiment.

Positives

  • A significant institutional investor, Dodge & Cox, maintains a substantial 10.2% stake in Zimmer Biomet Holdings, Inc., which can be interpreted as a continued vote of confidence in the company's long-term prospects.

Industry Context

This filing is a routine disclosure of a significant ownership stake by an institutional investor in a publicly traded medical device company. It reflects an investment decision by Dodge & Cox within the healthcare sector, indicating their continued interest in companies like Zimmer Biomet Holdings.

Stakeholder Impact

  • Shareholders: Provides transparency regarding a significant institutional holder's stake in the company, offering insight into major ownership positions.
  • Investment Community: Offers insight into the holdings of a major investment adviser, which may be considered by other investors in their own portfolio decisions.

Key Dates

DateDescription
04/30/2025Date of event which requires filing of this statement
05/06/2025Date of filing of this statement

Keywords

Zimmer Biomet Holdings, Dodge & Cox, Schedule 13G, Beneficial Ownership, Institutional Investor, Common Stock, SEC Filing, Investment Adviser, ZB, Medical Devices

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.